Bristol Myers Squibb to Present Data from Innovative Cardiovascular Portfolio at the American Heart Association Scientific Sessions 2023
New clinical analyses and real-world data continue to demonstrate the benefit of treatment with CAMZYOS (mavacamten) for patients with symptomatic obstructive HCM
United States Roland Chen Pfizer Alliance York Heart Association Bristol Myers Squibb A Us Single Center
Source: dicardiology.com